Analytical Data
-
基因名
BPIFB1
- Application
-
别名
BPIFB1；C20orf114；LPLUNC1；BPI fold-containing family B member 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TDL5
-
表达区间
1-484aa
-
氨基酸序列
MAGPWTFTLL CGLLAATLIQ ATLSPTAVLI LGPKVIKEKL TQELKDHNAT SILQQLPLLS AMREKPAGG IPVLGSLVNT VLKHIIWLKV ITANILQLQV KPSANDQELL VKIPLDMVAG FNTPLVKTI VEFHMTTEAQ ATIRMDTSAS GPTRLVLSDC ATSHGSLRIQ LLHKLSFLVN ALAKQVMNL LVPSLPNLVK NQLCPVIEAS FNGMYADLLQ LVKVPISLSI DRLEFDLLYP AIKGDTIQL YLGAKLLDSQ GKVTKWFNNS AASLTMPTLD NIPFSLIVSQ DVVKAAVAAV LSPEEFMVL LDSVLPESAH RLKSSIGLIN EKAADKLGST QIVKILTQDT PEFFIDQGHA KVAQLIVLE VFPSSEALRP LFTLGIEASS EAQFYTKGDQ LILNLNNISS DRIQLMNSGI GWFQPDVLK NIITEIIHSI LLPNQNGKLR SGVPVSLVKA LGFEAAESSL TKDALVLTPA SLWKPSSPV SQ
-
分子量
52 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BPIFB1, or BPI fold-containing family B member 1, is a protein implicated in various biological processes, including immune response and lipid metabolism. Research has increasingly focused on its role in respiratory biology, where it is believed to contribute to the innate immune defense mechanisms in the lungs. BPIFB1 exhibits structural similarities to bactericidal/permeability-increasing proteins, suggesting it may participate in pathogen recognition and clearance. Alterations or deficiencies in BPIFB1 expression have been associated with lung diseases, including chronic obstructive pulmonary disease (COPD) and asthma, highlighting its potential as a biomarker for these conditions. Recombinant BPIFB1 protein studies allow for deeper understanding of its functional properties, including binding to pathogens and involvement in inflammatory responses. By utilizing recombinant technology, researchers aim to characterize BPIFB1's interactions with lipopolysaccharides and other microbial components, elucidating its protective roles in the respiratory system. Additionally, understanding the molecular mechanisms governing BPIFB1 function could pave the way for therapeutic strategies targeting respiratory infections and inflammatory diseases. Overall, the investigation of BPIFB1 as a recombinant protein serves as a promising avenue for advancing our comprehension of its biological significance and potential clinical applications.
